ALKS

ALKERMES PLC

Healthcare | Mid Cap

$0.30

EPS Forecast

$343.2

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2025-09-30
NKTRNektar TherapeuticsBMRNBiomarin Pharmaceutical IncALNYAlnylam Pharmaceuticals IncPAHCPhibro Animal Health CorpSRPTSarepta Therapeutics IncJAZZJazz Pharmaceuticals PlcIONSIonis Pharmaceuticals IncRAREUltragenyx Pharmaceutical IncSAGESage Therapeutics Inc